MULTIDRUG-RESISTANCE IN PEDIATRIC MALIGNANCIES

被引:39
作者
CHAN, HSL
DEBOER, G
HADDAD, G
GALLIE, BL
LING, V
机构
[1] UNIV TORONTO,TORONTO,ON,CANADA
[2] TORONTO SUNNYBROOK REG CANC CTR,TORONTO,ON,CANADA
[3] ONTARIO CANC INST,TORONTO,ON M4X 1K9,CANADA
关键词
D O I
10.1016/S0889-8588(18)30096-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many sensitive immunohistochemical and molecular biologic tools have been developed to detect the multidrug resistance P-glycoprotein in tumor samples. In this article, the suitability of these tools for clinical use is assessed and evidence for the relevance of P-glycoprotein in mediating resistance to chemotherapy for treatment of childhood malignancies is evaluated. Preliminary results from some of the current studies suggest that pharmacologic modulation of normally effective chemotherapy might overcome some therapeutic failures owing to overexpression of P-glycoprotein in certain malignancies with lower levels of multidrug resistance.
引用
收藏
页码:275 / 318
页数:44
相关论文
共 146 条
[1]  
ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1763
[2]  
BAKER RM, 1989, DRUG RESISTANCE MECH, P167
[3]  
BATES SE, 1991, AM J PATHOL, V139, P305
[4]   UNKNOTTING THE COMPLEXITIES OF MULTIDRUG RESISTANCE - THE INVOLVEMENT OF DNA TOPOISOMERASES IN DRUG-ACTION AND RESISTANCE [J].
BECK, WT .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22) :1683-1685
[5]   CORRELATION OF MDR1 GENE-EXPRESSION WITH CHEMOTHERAPY IN NEURO-BLASTOMA [J].
BOURHIS, J ;
BENARD, J ;
HARTMANN, O ;
BOCCONGIBOD, L ;
LEMERLE, J ;
RIOU, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (18) :1401-1405
[6]   IMPACT OF INTENSIFIED THERAPY ON CLINICAL OUTCOME IN INFANTS AND CHILDREN WITH NEUROBLASTOMA - THE ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL EXPERIENCE, 1962 TO 1988 [J].
BOWMAN, LC ;
HANCOCK, ML ;
SANTANA, VM ;
HAYES, FA ;
KUN, L ;
PARHAM, DM ;
FURMAN, WL ;
RAO, BN ;
GREEN, AA ;
CRIST, WM .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1599-1608
[7]  
BRADLEY G, 1989, CANCER RES, V49, P2790
[8]   INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].
BRODEUR, GM ;
SEEGER, RC ;
BARRETT, A ;
BERTHOLD, F ;
CASTLEBERRY, RP ;
DANGIO, G ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
FREEMAN, AI ;
HAASE, G ;
HARTMANN, O ;
HAYES, FA ;
HELSON, L ;
KEMSHEAD, J ;
LAMPERT, F ;
NINANE, J ;
OHKAWA, H ;
PHILIP, T ;
PINKERTON, CR ;
PRITCHARD, J ;
SAWADA, T ;
SIEGEL, S ;
SMITH, EI ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881
[9]  
CAIRO MS, 1989, CANCER RES, V49, P1063
[10]  
CAMPOS L, 1992, BLOOD, V79, P473